| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |